Sunday, April 10, 2016 12:40:51 PM
Who owns the patent for autologous dendritic cells pulse with autologous glioblastoma peptides (which by the way it turns out BCG is used in the pulse process)?
ANSWER: The Regent of the University of California.
“Methods for the Detection and Treatment of Neural Cancer” Patent number: 6558668 Patent number: 7192704
http://patents.justia.com/patent/6558668
http://patents.justia.com/patent/7192704
“Composition and Methods for the Detection and Treatment of Multiple Cancers” Patent number 7204982
http://patents.justia.com/patent/7204982
Who owns the various patent for administration and activation of dendritic cells (including precursors) which is used in combination of the above, pulsed method?
ANSWER: NWBT.
https://www.google.com/#q=inassignee:%22NorthWest+Biotherapeutics,+Inc.%22&hl=en&tbm=pts&start=0
Who will own the Patent of "Combination for Checkpoint Inhibitor and Therapeutics to Treat Cancer” if granted? They both will, as will Cognate, but NWBT will have to pay licensing rights, if one goes by the agreement above. If NWBO goes bankrupt, private Cognate and RevImmune (both LP companies), will own the rights to combine DC technology with lysate with CI.
AND, just incase you need to see the tumor lysate portion of the patent:
UCLA was hired to
AND therefore, circling back to when IND's were created, well that would be after this agreement was in place. Both IND #10206, Phase III (without TLR) and IND #11053 Phase II (with TLR) were created after 2001. All patents after this agreement were available to use. They are the same DCVax-L lysate-pulsed product, used in Phase I/II as per the SEC statement. Manufacturing difference relate to Cognate verses UCLA creating the product, and the use of TLR.
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM